Andere Sprachen Eris Lifesciences Limited

Aktien

A2DU61

INE406M01024

ERIS

Pharmazeutika

Verzögert NSE India S.E. Andere Börsenplätze 08:27:40 09.02.2026			% 5 Tage	Veränd. 1. Jan.
1.460,30 ^INR	+2,05 %		+5,54 %	-3,02 %

18.12.	Eris Lifesciences Limited kündigt das Ausscheiden von Rajeev Dalal als nicht geschäftsleitender, unabhängiger Direktor zum 18. Dezember 2025 an	CI
25.11.	Eris Lifesciences übernimmt restliche 30 % an Swiss Parenterals für 4,23 Milliarden INR	MT

Andere Sprachen

18.12.	Eris Lifesciences Limited Announces Cessation of Rajeev Dalal as A Non-Executive, Independent Director, Effective December 18, 2025
25.11.	Eris Lifesciences to Acquire Remaining 30% in Swiss Parenterals for INR4.23 Billion
24.11.	Eris Lifesciences buys 30% stake of unit Swiss Parenterals Ltd
24.11.	Eris Lifesciences Limited agreed to acquire remaining 30% stake in Swiss Parenterals Limited from Naishadh Shah for INR 3.8 billion.
19.11.	Eris Lifesciences to consider acquiring 30% stake in Swiss Parenterals
12.11.	Eris Lifesciences posts Sept-qtr consol net profit 1.2 billion rupees
12.11.	Eris Lifesciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
12.11.	Eris Lifesciences Sept-quarter consol net profit 1.2 billion rupees
26.08.25	Eris Lifesciences Gets Brazilian Regulator's Approval for Ahmedabad, India Unit
26.08.25	Eris receives ANVISA approval for sterile injectable facility
25.08.25	Eris Lifesciences Receives ANVISA Approval At Its Ahmedabad Campus
05.08.25	Eris Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
05.08.25	Eris Lifesciences' Consolidated Attributable Profit Climbs in Fiscal Q1
05.08.25	Eris Lifesciences June-qtr consol net profit 1.18 bln rupees
19.05.25	Eris Lifesciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025
19.05.25	DIARY-India economic, corporate events on May 19
07.03.25	Eris Lifesciences Sells Two Subsidiaries for INR8.62 Billion as Part of Restructuring
06.03.25	Eris Lifesciences Limited Appoints Murari Ranganathan as President, Cardiometabolic Business
28.02.25	Eris Lifesciences Acquires 30% stake in Levim Lifetech
21.02.25	Eris Lifesciences Limited Avails Credit Facilities
20.02.25	Eris Lifesciences Issues INR15 Billion Corporate Guarantee for Subsidiary
07.02.25	Eris Lifesciences Limited Approves Declaration of Interim Dividend the Financial Year 2024-2025, Payable on or Before March 9, 2025
07.02.25	Eris Lifesciences Interim Dividend Of 7.35 Rupees Per Share
04.02.25	Eris Lifesciences' Consolidated Profit Slides in Fiscal Q3; Shares Down 4%
04.02.25	Eris Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Eris Lifesciences Limited

Aktien

A2DU61

INE406M01024

ERIS

Pharmazeutika

Andere Sprachen

Filter